BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 36 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,965,372 | +15.9% | 4,003,000 | +17.6% | 0.00% | – |
| Q2 2023 | $3,421,070 | -61.8% | 3,403,000 | -60.4% | 0.00% | – |
| Q1 2023 | $8,962,585 | +43.1% | 8,593,000 | +47.4% | 0.00% | – |
| Q4 2022 | $6,262,536 | +20.6% | 5,828,000 | +11.5% | 0.00% | – |
| Q3 2022 | $5,192,000 | -22.1% | 5,228,000 | -22.0% | 0.00% | – |
| Q2 2022 | $6,661,000 | +36.4% | 6,703,000 | +37.4% | 0.00% | – |
| Q1 2022 | $4,884,000 | +34.6% | 4,878,000 | +40.3% | 0.00% | – |
| Q4 2021 | $3,628,000 | +4.2% | 3,478,000 | 0.0% | 0.00% | – |
| Q3 2021 | $3,481,000 | +16.7% | 3,478,000 | +16.8% | 0.00% | – |
| Q2 2021 | $2,984,000 | – | 2,978,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 30,062 | $30,276,000 | 2.06% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 45,103,000 | $45,311,000 | 0.72% |
| MACKAY SHIELDS LLC | 76,920,000 | $77,403,000 | 0.68% |
| LOOMIS SAYLES & CO L P | 2,277,794 | $175,618,000 | 0.24% |
| KBC Group NV | 300,000 | $30,339,000 | 0.11% |
| CAMDEN ASSET MANAGEMENT L P /CA | 3,200,000 | $3,204,000 | 0.10% |
| Allianz Asset Management GmbH | 116,770,000 | $118,163,000 | 0.09% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,143,000 | $3,168,000 | 0.07% |
| Lombard Odier Asset Management (Europe) Ltd | 1,600,000 | $1,610,000 | 0.06% |
| THRIVENT FINANCIAL FOR LUTHERANS | 16,400,000 | $16,421,000 | 0.03% |